Dana M. Omer, MD

Research Fellow
Department of Surgery, Memorial Sloan Kettering Cancer Center, United States

Presentation(s):

• 21: Organ Preservation, Compliance and Toxicity in Rectal Cancer Patients Treated with Total Neoadjuvant Therapy: A Post Hoc Analysis of the of the OPRA Phase II Trial

  Thursday, March 23, 2023
  10:16 AM – 10:26 AM

  Disclosure information not submitted.